Cargando…

Epidemiology of lymphoid malignancies: last decade update

BACKGROUND: The non-Hodgkin lymphomas are 12(th) most prevalent cancers in Europe. No recent update in the epidemiology of these lymphomas has been performed in our country. We diagnosed 701 new lymphomas during the period beginning January 1, 2000 and ending December 31, 2009 in our center. FINDING...

Descripción completa

Detalles Bibliográficos
Autores principales: Novelli, Silvana, Briones, Javier, Sierra, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing AG 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599205/
https://www.ncbi.nlm.nih.gov/pubmed/23520573
http://dx.doi.org/10.1186/2193-1801-2-70
_version_ 1782262910426284032
author Novelli, Silvana
Briones, Javier
Sierra, Jorge
author_facet Novelli, Silvana
Briones, Javier
Sierra, Jorge
author_sort Novelli, Silvana
collection PubMed
description BACKGROUND: The non-Hodgkin lymphomas are 12(th) most prevalent cancers in Europe. No recent update in the epidemiology of these lymphomas has been performed in our country. We diagnosed 701 new lymphomas during the period beginning January 1, 2000 and ending December 31, 2009 in our center. FINDINGS: The most frequent lymphoma was diffuse large B cell lymphoma, followed by follicular lymphoma and then classic Hodgkin’s disease. The male:female ratio is 1.2:1. Diagnosis by age showed that non-Hodgkin’s lymphoma is by far more frequent in the 61-80 years old patients. On the other hand, classic Hodgkin’s lymphoma is more frequent in the 20-40 years old population. CONCLUSION: Our results are very similar to those published by other centers in Europe and United States
format Online
Article
Text
id pubmed-3599205
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer International Publishing AG
record_format MEDLINE/PubMed
spelling pubmed-35992052013-03-19 Epidemiology of lymphoid malignancies: last decade update Novelli, Silvana Briones, Javier Sierra, Jorge Springerplus Short Report BACKGROUND: The non-Hodgkin lymphomas are 12(th) most prevalent cancers in Europe. No recent update in the epidemiology of these lymphomas has been performed in our country. We diagnosed 701 new lymphomas during the period beginning January 1, 2000 and ending December 31, 2009 in our center. FINDINGS: The most frequent lymphoma was diffuse large B cell lymphoma, followed by follicular lymphoma and then classic Hodgkin’s disease. The male:female ratio is 1.2:1. Diagnosis by age showed that non-Hodgkin’s lymphoma is by far more frequent in the 61-80 years old patients. On the other hand, classic Hodgkin’s lymphoma is more frequent in the 20-40 years old population. CONCLUSION: Our results are very similar to those published by other centers in Europe and United States Springer International Publishing AG 2013-02-26 /pmc/articles/PMC3599205/ /pubmed/23520573 http://dx.doi.org/10.1186/2193-1801-2-70 Text en © Novelli et al; licensee Springer. 2013 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Report
Novelli, Silvana
Briones, Javier
Sierra, Jorge
Epidemiology of lymphoid malignancies: last decade update
title Epidemiology of lymphoid malignancies: last decade update
title_full Epidemiology of lymphoid malignancies: last decade update
title_fullStr Epidemiology of lymphoid malignancies: last decade update
title_full_unstemmed Epidemiology of lymphoid malignancies: last decade update
title_short Epidemiology of lymphoid malignancies: last decade update
title_sort epidemiology of lymphoid malignancies: last decade update
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599205/
https://www.ncbi.nlm.nih.gov/pubmed/23520573
http://dx.doi.org/10.1186/2193-1801-2-70
work_keys_str_mv AT novellisilvana epidemiologyoflymphoidmalignancieslastdecadeupdate
AT brionesjavier epidemiologyoflymphoidmalignancieslastdecadeupdate
AT sierrajorge epidemiologyoflymphoidmalignancieslastdecadeupdate